posted Apr 8, 2010 5:59 AM by EBF European Bioanalysis Forum
[
updated Apr 8, 2010 6:14 AM
]
| 17-Jun-2010 |
| |
|
|
| 8:30 - 8:40 |
Welcome & Introduction |
|
| |
|
|
| |
|
|
| 08:40 - 09:30 |
Plenary session |
|
| scope of the session |
|
| A high level overview will be presented of the usage and new developments of DBS in the bioanalytical lab as well as the application of the technique in drug discovery and development. The session aims at providing the audience a prepared mind to actively participate in the stimulating discussion during the focussed sessions of day 1 and day 2 of the conference. |
| |
|
|
| |
|
|
| 9:30 - 10:00 |
Break |
|
| |
|
|
| |
|
|
| 10:00 - 11:30 |
Challenges and potential of DBS in Drug Discovery |
| scope of the session |
|
| This session will focus on the use of dried blood spot applications within the discovery environment. High quality presentations are expected across all aspects of discovery support fostering a informative dialogue on how DBS is impacting the non-regulatory environment. Discussion topics are expected to range from how the use of DBS facilitates the easy of collection, impact to pharmacology modelling and how DBs enables obtaining robust data from small animal models as well as other applications |
| |
|
|
| 10:00 - 10:20 |
invited speaker |
|
| 10:20 - 10:35 |
oral presentation |
|
| 10:35 - 10:50 |
oral presentation |
|
| 10:50 - 11:05 |
oral presentation |
|
| 11:05 - 11:30 |
panel discussion |
|
| |
|
|
| |
|
|
| 11:30 - 12:30 |
Poster Session |
|
| |
|
|
| |
|
|
| 12:30 - 13:30 |
Lunch |
|
| |
|
|
| |
|
|
| 13:30 - 15:00 |
Challenges and potential of DBS in Toxicology |
| scope of the session |
|
The use of Dried Blood Spots for TK sampling offers the potential for significant benefits in terms of animal welfare and the 3Rs, not least being the potential to remove satellite TK animals completely. In addition, by reducing sample volumes and removing the need to derive plasma the animal sampling processes can be simplified greatly. However, if the full benefits of the technique are to be realised, then the implications of these changes must be fully understood and put into context.
The aim of this session is to engage a multi-disciplined audience in understanding the huge potential of DBS in this area, whilst being mindful of the challenges which must be addressed to make it a success.
|
| 13:30 - 13:50 |
invited speaker |
|
| 13:50 - 14:05 |
oral presentation |
|
| 14:05 - 14:20 |
oral presentation |
|
| 14:20 - 14:35 |
oral presentation |
|
| 14:35 - 15:00 |
panel discussion |
|
| |
|
|
| |
|
|
| 15:00 - 15:30 |
Break |
|
| |
|
|
| |
|
|
| 15:30 -17:30 |
DBS and bioanalysis: challenges, successes, new developments |
| scope of the session |
|
| This session will give bioanalysts the opportunity to share and discuss their experiences, both positive and negative, on developing DBS methods and, subsequentially, the qualification/validation of DBS methods, join an open discussion on different ways at looking at the validation parameters of DBS methods, and share cutting edge technology developments. |
| 15:30 - 16:00 |
plenary speaker |
|
| 16:00 - 16:15 |
oral presentation |
|
| 16:15 - 16:30 |
oral presentation |
|
| 16:30 - 16:45 |
oral presentation |
|
| 16:45 - 17:00 |
oral presentation |
|
| 17:00 - 17:30 |
panel discussion |
|
| |
|
|
| |
|
|
| 17:30 |
end of day 1 |
|
| 17:30 - 18:30 |
Cocktail reception |
| |
|
